The efficacy and role of venetoclax/venetoclax: How to accurately target cancer cells?

As a targeted drug, Venetoclax has shown remarkable efficacy in the field of cancer treatment, especially in the treatment of hematological malignancies such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Venaclat's main mechanism of action is by precisely targeting the BCL-2 protein, making it a drug with revolutionary therapeutic potential.

BCL-2 protein is an anti-apoptotic protein that is present in many cancer cells and helps cancer cells survive by inhibiting apoptosis. Overexpression of this protein is key to the ability of many tumor cells to evade normal death mechanisms. By specifically binding to and inhibiting the function of BCL-2 protein, venetoclax prevents cancer cells from evading the normal apoptosis process. Through this mechanism, venetoclax can effectively reduce the survival and proliferation of cancer cells and promote their death.

Clinically, venetoclax has been shown to have significant therapeutic effects on a variety of blood cancers. In the treatment of chronic lymphocytic leukemia (CLL), venetoclax can reduce the survival of leukemia cells by inhibiting BCL-2, significantly reduce the tumor burden in patients, and improve the overall survival of patients. In addition, the efficacy of venetoclax can be enhanced when combined with other medications, making it an important treatment option. Especially when combined with anti-CD20 antibodies such as rituximab, the therapeutic effect is further enhanced.

Veneclar also shows promise as a treatment for acute myeloid leukemia (AML), especially those with specific genetic mutations. In AML patients, venetoclax is usually used in combination with chemotherapy drugs, which can help break the anti-apoptotic mechanism of cancer cells and improve the therapeutic effect. Through combined use, venetoclax can effectively enhance the effect of chemotherapy drugs, thereby improving the patient's cure rate.

Reference materials:https://www.venclexta.com/